Supriya Lifescience Limited

NSE SUPRIYA.NS

Supriya Lifescience Limited Market Capitalization on January 14, 2025: USD 621.17 M

Supriya Lifescience Limited Market Capitalization is USD 621.17 M on January 14, 2025, a 106.15% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Supriya Lifescience Limited 52-week high Market Capitalization is USD 769.65 M on November 22, 2024, which is 23.90% above the current Market Capitalization.
Supriya Lifescience Limited 52-week low Market Capitalization is USD 285.75 M on February 02, 2024, which is -54.00% below the current Market Capitalization.
Supriya Lifescience Limited average Market Capitalization for the last 52 weeks is USD 464.87 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NSE: SUPRIYA.NS

Supriya Lifescience Limited

CEO	Dr. Satish Waman Wagh
IPO Date	Dec. 28, 2021
Location	India
Headquarters	207/208 Udyog Bhavan
Employees	448
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Supriya Lifescience Ltd., a bulk drugs company, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients worldwide. It offers active pharmaceutical ingredients, such as anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, smoking cessation, antihypertensive, and anti-malarial products, as well as vitamins, feed additives, xanthine derivatives and beverages, and phytochemicals. The company was founded in 1987 and is headquartered in Mumbai, India.

Key trends

Past 5 years